Assertio Holdings, Inc.

  • Market Cap: Micro Cap
  • Industry: Pharmaceuticals & Biotechnology
  • ISIN: US04546C2052
USD
0.78
0.03 (3.53%)
  • Price Points
  • Score
  • Mojo Parameters
  • Total Return
  • News and Corporate Actions
  • Key factors
  • Shareholding
  • Financials
  • CompanyCV
stock-recommendationScore
Click here to find our call on this stock
Strong Sell
Sell
Hold
Buy
Strong Buy

MarketsMojo — Loved in India, Now Global

The power of Mojo is now in 29 countries. Explore global equities with the same cutting-edge features you love.

Comparison
Company
Score
Quality
Valuation
Financial
Technical
Lexicon Pharmaceuticals, Inc.
Assertio Holdings, Inc.
IGM Biosciences, Inc.
scPharmaceuticals, Inc.
Y-mAbs Therapeutics, Inc.
Ocular Therapeutix, Inc.
Vanda Pharmaceuticals, Inc.
AC Immune SA
Compass Therapeutics, Inc.
Inozyme Pharma, Inc.
Acumen Pharmaceuticals, Inc.
Why is Assertio Holdings, Inc. ?
1
Strong ability to service debt as the company has a low Debt to EBITDA ratio of 1.53 times
2
Positive results in Jun 25
  • DEBT-EQUITY RATIO (HY) Lowest at -56.16 %
  • NET PROFIT(9M) Higher at USD -35.41 MM
  • CASH AND EQV(HY) Highest at USD 185.51 MM
3
High Institutional Holdings at 61.62%
  • These investors have better capability and resources to analyse fundamentals of companies than most retail investors.
stock-recommendationReal-Time Research Report
Verdict Report
How much should you buy?
  1. Overall Portfolio exposure to Assertio Holdings, Inc. should be less than 10%
  2. Overall Portfolio exposure to Pharmaceuticals & Biotechnology should be less than 30%

(If sector exposure > 30%, please use optimiser tool to see which are the best stocks to hold in Pharmaceuticals & Biotechnology)

When to exit? - We will constantly monitor the company and suggest at the appropriate time to exit from the stock

Is Assertio Holdings, Inc. for you?

High Risk, Low Return

Absolute
Risk Adjusted
Volatility
Assertio Holdings, Inc.
-21.5%
-0.69
51.06%
S&P 500
13.22%
0.61
20.17%
stock-recommendationQuality
stock-summaryManagement Risk
stock-summaryGrowth
stock-summaryCapital Structure
stock-recommendation
Quality grade scale :

Below Average, Average, Good, Excellent

Quality key factors
Factor
Value
Sales Growth (5y)
-5.56%
EBIT Growth (5y)
4.54%
EBIT to Interest (avg)
-0.18
Debt to EBITDA (avg)
1.53
Net Debt to Equity (avg)
-0.39
Sales to Capital Employed (avg)
0.74
Tax Ratio
0.54%
Dividend Payout Ratio
0
Pledged Shares
0
Institutional Holding
61.62%
ROCE (avg)
7.72%
ROE (avg)
11.46%
stock-recommendationValuation
Valuation Scorecard stock-summary
stock-recommendation
Valuation grade scale :

Very Risky, Risky, Very Expensive, Expensive, Fair, Attractive, Very Attractive

Valuation Key Factors stock-summary
Factor
Value
P/E Ratio
NA (Loss Making)
Industry P/E
Price to Book Value
0.58
EV to EBIT
-0.79
EV to EBITDA
6.51
EV to Capital Employed
0.32
EV to Sales
0.17
PEG Ratio
NA
Dividend Yield
NA
ROCE (Latest)
-39.77%
ROE (Latest)
-21.61%
stock-recommendationTechnicals
Technical key factors
Indicator
Weekly
Monthly
MACD
Bearish
Mildly Bullish
RSI
No Signal
No Signal
Bollinger Bands
Bearish
Bearish
Moving Averages
Mildly Bullish (Daily)
KST
Mildly Bearish
Mildly Bullish
Dow Theory
Mildly Bearish
Mildly Bearish
OBV
Mildly Bullish
Mildly Bullish
stock-recommendation Technical Indicator Scale: Bearish, Mildly Bearish, Sideways, Mildly Bullish, Bullish  Turned 
Technical Movement
stock-recommendationFinancial Trend
Financial Trend Scorecard stock-summary
stock-recommendation
Financial Trend scale:

Very Negative, Negative, Flat, Positive, Very Positive, Outstanding

5What is working for the Company
DEBT-EQUITY RATIO (HY)

Lowest at -56.16 %

NET PROFIT(9M)

Higher at USD -35.41 MM

CASH AND EQV(HY)

Highest at USD 185.51 MM

-20What is not working for the Company
OPERATING CASH FLOW(Y)

Lowest at USD 18.06 MM

DEBTORS TURNOVER RATIO(HY)

Lowest at 2.05 times

PRE-TAX PROFIT(Q)

Lowest at USD -16.3 MM

RAW MATERIAL COST(Y)

Grown by 37.09% (YoY

NET PROFIT(Q)

Lowest at USD -16.35 MM

EPS(Q)

Lowest at USD -0.17

Here's what is working for Assertio Holdings, Inc.
Debt-Equity Ratio
Lowest at -56.16 % and Grown
In each half year in the last five Semi-Annual periods
MOJO Watch
The company has been reducing its borrowing as compared to equity capital

Debt-Equity Ratio

Cash and Eqv
Highest at USD 185.51 MM
in the last six Semi-Annual periods
MOJO Watch
Short Term liquidity is improving

Cash and Cash Equivalents

Here's what is not working for Assertio Holdings, Inc.
Pre-Tax Profit
At USD -16.3 MM has Fallen at -179.94%
over average net sales of the previous four periods of USD -5.82 MM
MOJO Watch
Near term Pre-Tax Profit trend is very negative

Pre-Tax Profit (USD MM)

Net Profit
At USD -16.35 MM has Fallen at -178.93%
over average net sales of the previous four periods of USD -5.86 MM
MOJO Watch
Near term Net Profit trend is very negative

Net Profit (USD MM)

Operating Cash Flow
Lowest at USD 18.06 MM and Fallen
In each year in the last three years
MOJO Watch
The company's cash revenues from business operations are falling

Operating Cash Flows (USD MM)

Pre-Tax Profit
Lowest at USD -16.3 MM and Fallen
In each period in the last five periods
MOJO Watch
Near term Pre-Tax Profit trend is very negative

Pre-Tax Profit (USD MM)

Debtors Turnover Ratio
Lowest at 2.05 times and Fallen
In each half year in the last five Semi-Annual periods
MOJO Watch
Company's pace of selling Debtors has slowed

Debtors Turnover Ratio

Net Profit
Lowest at USD -16.35 MM
in the last five periods
MOJO Watch
Near term Net Profit trend is negative

Net Profit (USD MM)

EPS
Lowest at USD -0.17
in the last five periods
MOJO Watch
Declining profitability; company has created lower earnings for shareholders

EPS (USD)

Raw Material Cost
Grown by 37.09% (YoY)
MOJO Watch
The company's ability to pass on the cost of raw materials to customers has deteriorated; this may lead to a fall in profit margin

Raw Material Cost as a percentage of Sales